Multinational Analysis of Estimated Health Care Costs Related to Extended-Interval Fixed Dosing of Checkpoint Inhibitors
Sign Up to like & getrecommendations! Published in 2023 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2023.0490
Abstract: Key Points Question Is extended-interval fixed dosing of pembrolizumab associated with increased health care costs? Findings This economic evaluation including simulated patients found that using the US Food and Drug Administration–labeled pembrolizumab dose of 400… read more here.
Keywords: health care; care costs; extended interval; interval fixed ... See more keywords